ESTIMATED
04/23/2024
04/23/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 4 | $1.86 | $1.86 | $1.86 |
Q2 2024 | 12 | $2.26 | $2.38 | $2.33 |
Q3 2024 | 5 | $2.31 | $2.31 | $2.31 |
Q4 2024 | 5 | $2.14 | $2.14 | $2.14 |
Q1 2025 | 6 | $2.19 | $2.19 | $2.19 |
Q2 2025 | 6 | $2.51 | $2.51 | $2.51 |
Q3 2025 | 6 | $2.48 | $2.48 | $2.48 |
Q4 2025 | 6 | $2.31 | $2.31 | $2.31 |
Q1 2026 | 9 | $2.38 | $2.38 | $2.38 |
Q2 2026 | 9 | $2.73 | $2.73 | $2.73 |
Q3 2026 | 9 | $2.70 | $2.70 | $2.70 |
Q4 2026 | 9 | $2.50 | $2.50 | $2.50 |
Quest Diagnostics Incorporated last posted its earnings results on Tuesday, April 23rd, 2024. The company reported $2.04 earnings per share for the quarter, topping analysts' consensus estimates of $1.86 by $0.18. The company had revenue of 2.37 B for the quarter and had revenue of 9.25 B for the year. Quest Diagnostics Incorporated has generated $8 earnings per share over the last year ($7.52 diluted earnings per share) and currently has a price-to-earnings ratio of 18.43. Quest Diagnostics Incorporated has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 23rd, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 04/24/2024 | Q1 2024 | $1.74 | $2.29 B | $2.37 B | 02/22/2024 | Q4 2023 | $1.71 | $2.25 B | $2.29 B | 10/25/2023 | Q3 2023 | $1.99 | $2.30 B | 07/27/2023 | Q2 2023 | $2.09 | $2.34 B | 04/28/2023 | Q1 2023 | $1.79 | $2.20 B | $2.33 B | 02/21/2023 | Q4 2022 | $0.89 | $2.26 B | $2.33 B | 10/21/2022 | Q3 2022 | $2.19 | $2.49 B | 07/22/2022 | Q2 2022 | $1.99 | $2.45 B | 04/22/2022 | Q1 2022 | $2.97 | $2.61 B | 02/28/2022 | Q4 2021 | $3.19 | $2.68 B | $2.74 B | 10/22/2021 | Q3 2021 | $4.11 | $2.45 B | $2.77 B | 07/23/2021 | Q2 2021 | $5.05 | $2.39 B | $2.55 B | 04/23/2021 | Q1 2021 | $3.52 | $2.72 B | 02/22/2021 | Q4 2020 | $4.28 | $2.93 B | $3.00 B | 10/23/2020 | Q3 2020 | $4.20 | $2.72 B | $2.79 B | 07/24/2020 | Q2 2020 | $1.38 | $1.69 B | $1.83 B | 05/04/2020 | Q1 2020 | $0.74 | $1.82 B | 02/20/2020 | Q4 2019 | $1.88 | $1.92 B | $1.93 B | 10/23/2019 | Q3 2019 | $1.59 | $1.94 B | $1.96 B | 07/24/2019 | Q2 2019 | $1.67 | $1.94 B | $1.95 B |
---|
A. Quest Diagnostics Incorporated has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 23rd, 2024 based off last year's report dates.
A. In the previous quarter, Quest Diagnostics Incorporated (NYSE:DGX) reported $2.04 earnings per share (EPS) to beat the analysts' consensus estimate of $1.86 by $0.18.
A. The conference call for Quest Diagnostics Incorporated's latest earnings report can be listened to online.
A. The conference call transcript for Quest Diagnostics Incorporated's latest earnings report can be read online.
A. Quest Diagnostics Incorporated (NYSE:DGX) has a recorded annual revenue of $9.25 B.
A. Quest Diagnostics Incorporated (NYSE:DGX) has a recorded net income of $9.25 B. Quest Diagnostics Incorporated has generated $7.59 earnings per share over the last four quarters.
A. Quest Diagnostics Incorporated (NYSE:DGX) has a price-to-earnings ratio of 18.43 and price/earnings-to-growth ratio is 3.4.